Ionis Pharmaceuticals, Inc. (IONS)
61.05
-1.38
(-2.21%)
USD |
NASDAQ |
Aug 28, 16:00
61.05
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Free Cash Flow : -567.50M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -567.50M |
| March 31, 2026 | -977.73M |
| December 31, 2025 | -325.67M |
| September 30, 2025 | -309.48M |
| June 30, 2025 | -282.41M |
| March 31, 2025 | -559.62M |
| December 31, 2024 | -551.29M |
| September 30, 2024 | -374.21M |
| June 30, 2024 | -375.18M |
| March 31, 2024 | -345.48M |
| December 31, 2023 | -335.52M |
| September 30, 2023 | -573.62M |
| June 30, 2023 | -492.84M |
| March 31, 2023 | -405.00M |
| December 31, 2022 | -294.47M |
| September 30, 2022 | 110.43M |
| June 30, 2022 | 81.74M |
| March 31, 2022 | 35.38M |
| December 31, 2021 | 12.90M |
| September 30, 2021 | -95.70M |
| June 30, 2021 | -58.77M |
| March 31, 2021 | -45.24M |
| December 31, 2020 | -5.156M |
| September 30, 2020 | 178.11M |
| June 30, 2020 | 170.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 193.80M |
| December 31, 2019 | 314.82M |
| September 30, 2019 | 153.82M |
| June 30, 2019 | 153.71M |
| March 31, 2019 | 678.60M |
| December 31, 2018 | 585.24M |
| September 30, 2018 | 485.20M |
| June 30, 2018 | 524.88M |
| March 31, 2018 | 27.93M |
| December 31, 2017 | 136.29M |
| September 30, 2017 | 93.16M |
| June 30, 2017 | 105.36M |
| March 31, 2017 | 71.59M |
| December 31, 2016 | -123.63M |
| September 30, 2016 | -134.44M |
| June 30, 2016 | -118.99M |
| March 31, 2016 | -20.36M |
| December 31, 2015 | 11.99M |
| September 30, 2015 | 118.59M |
| June 30, 2015 | 82.39M |
| March 31, 2015 | -15.18M |
| December 31, 2014 | -4.819M |
| September 30, 2014 | -83.02M |
| June 30, 2014 | -20.87M |
| March 31, 2014 | 38.21M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Biogen, Inc. | 2.49B |
| BridgeBio Pharma, Inc. | -437.79M |
| Vertex Pharmaceuticals, Inc. | 3.796B |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 565.53M |
| Cash from Investing (Quarterly) | 23.50M |
| Cash from Financing (Quarterly) | -412.29M |
| Free Cash Flow Per Share (Quarterly) | 3.309 |
| Free Cash Flow to Equity (Quarterly) | 967.92M |
| Free Cash Flow to Firm (Quarterly) | 569.67M |
| Free Cash Flow Yield | -5.70% |